Skip to content

Clinical trials

Phase 1/2 Carcinoma trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma Phase: Phase 1/2 Country / region: South Korea Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20092
20121
20172
20191
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Recruiting3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AVEO Pharmaceuticals, Inc.1
DualityBio Inc.1
Eisai Co., Ltd.1
Hanmi Pharmaceutical Company Limited1
Hoffmann-La Roche1
Inhibrx Biosciences, Inc1
Turning Point Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma7
Neoplasms6
Carcinoma, Non-Small-Cell Lung5
Lung Neoplasms4
Neoplasms by Histologic Type4
Neoplasms by Site4
Gastrointestinal Neoplasms3
Head and Neck Neoplasms3
Lung Diseases3
Neoplasms, Glandular and Epithelial3

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.